{"id":48261,"date":"2022-09-12T17:02:08","date_gmt":"2022-09-12T15:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/"},"modified":"2022-09-12T17:02:08","modified_gmt":"2022-09-12T15:02:08","slug":"ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/","title":{"rendered":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or \u201cThe Company\u201d) today confirmed that Chairman and CEO Debra A. Cafaro will accept the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership this evening at the organization\u2019s 11th<\/sup> Annual Visionary Awards Celebration and Gala.\n<\/p>\n

\nWCD is the only global membership organization and community of women corporate directors, with 2,500 members serving on 8,500 boards around the world. The Strategic Leadership award is given to a current woman CEO or board chair who demonstrates leadership through innovation, board and management team diversity and the successful pursuit of long-term strategic growth, while developing programs to mentor and promote female employees.\n<\/p>\n

\nThe WCD Visionary Awards celebrate individuals who exhibit an exceptional commitment to diversity, inclusion and women’s authority in the boardroom. Cafaro\u2019s unanimous selection recognizes her stellar leadership, sustained company success, ethical standards and focus on industry and community partnerships.\n<\/p>\n

\nSince being named CEO of Ventas in 1999, Cafaro has driven outsized growth and value creation for shareholders, helping to increase Ventas\u2019s market capitalization from $200 million in 2000 to $25 billion in 2022, and established the Company as an industry leader in environmental, social and governance matters. Cafaro has also fostered a culture at Ventas that prioritizes recruiting, developing and retaining a diverse workforce.\n<\/p>\n

\n\u201cThis award reflects Ventas\u2019s longstanding commitment to rigorous corporate governance standards, our efforts to drive diversity, equity and inclusion in the boardroom and throughout the Company, and the tremendous work of Ventas employees to deliver decades of outstanding growth and value creation,\u201d said Cafaro. \u201cI\u2019m honored to accept this award on behalf of Ventas directors and my colleagues, and I congratulate the other honorees on their accomplishments and success.\u201d\n<\/p>\n

\nAbout VENTAS
\n
<\/b>Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries \u2013 healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBJ Grant
\n
(877) 4-VENTAS\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or \u201cThe Company\u201d) today confirmed that Chairman and CEO Debra A. Cafaro will accept the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership this evening at the organization\u2019s 11th Annual Visionary Awards Celebration and Gala. WCD is the only global membership organization and community of women corporate … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48261","6":"format-standard","7":"category-industry"},"yoast_head":"\nVentas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or \u201cThe Company\u201d) today confirmed that Chairman and CEO Debra A. Cafaro will accept the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership this evening at the organization\u2019s 11th Annual Visionary Awards Celebration and Gala. WCD is the only global membership organization and community of women corporate ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-12T15:02:08+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors\",\"datePublished\":\"2022-09-12T15:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/\"},\"wordCount\":438,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/\",\"name\":\"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-09-12T15:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/","og_locale":"en_US","og_type":"article","og_title":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or \u201cThe Company\u201d) today confirmed that Chairman and CEO Debra A. Cafaro will accept the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership this evening at the organization\u2019s 11th Annual Visionary Awards Celebration and Gala. WCD is the only global membership organization and community of women corporate ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-12T15:02:08+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors","datePublished":"2022-09-12T15:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/"},"wordCount":438,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/","url":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/","name":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-09-12T15:02:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ventas-chairman-and-ceo-debra-a-cafaro-to-accept-2022-visionary-award-for-strategic-leadership-from-women-corporate-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ventas Chairman and CEO Debra A. Cafaro to Accept 2022 Visionary Award for Strategic Leadership from Women Corporate Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48261"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48261\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}